If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Basaglar ® (insulin glargine) injection
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What is the indication for Basaglar® (insulin glargine)?
Basaglar is indicated to improve glycemic control in patients with diabetes.
US_cFAQ_BIV037_INDICATION
en-US
Indication for Basaglar
Basaglar® (insulin glargine) 100 units/mL is a long-acting human insulin analog indicated to improve glycemic control in
- adults and pediatric patients with type 1 diabetes, and
- adults with type 2 diabetes.1
Basaglar is not recommended for the treatment of diabetic ketoacidosis.1
Enclosed Prescribing Information
Reference
1Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: April 19, 2022
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays